| P50 | author | Denise E Chou | Q96246984 |
| P2093 | author name string | Camilla H Casadei | |
| | Giti J Gross | |
| | Marianna Shnayderman Yugrakh | |
| P2860 | cites work | Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study | Q44515056 |
| | Effect of noninvasive vagus nerve stimulation on acute migraine: an open-label pilot study | Q46516642 |
| | Long-Term Pain Reduction Does Not Imply Improved Functional Outcome in Patients Treated With Combined Supraorbital and Occipital Nerve Stimulation for Chronic Migraine. | Q47830303 |
| | Preventive migraine treatment. | Q51767106 |
| | Supraorbital transcutaneous neurostimulation has sedative effects in healthy subjects | Q21261402 |
| | Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study | Q24598887 |
| | Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study | Q27347591 |
| | Safety and patients’ satisfaction of transcutaneous Supraorbital NeuroStimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population | Q27496206 |
| | EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force | Q28256451 |
| | The International Classification of Headache Disorders, 3rd edition (beta version) | Q29392338 |
| | Abnormal brain processing of cutaneous pain in migraine patients during the attack. | Q31115701 |
| | Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience | Q34019250 |
| | Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, double-blinded, controlled study | Q34033827 |
| | Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial | Q34035463 |
| | Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis | Q35692944 |
| | Transcutaneous supraorbital neurostimulation in "de novo" patients with migraine without aura: the first Italian experience | Q35876316 |
| | Neurostimulation for primary headache disorders | Q36653453 |
| | Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study | Q37047300 |
| | Occipital nerve stimulation for medically intractable headache. | Q37139982 |
| | Improved identification of allodynic migraine patients using a questionnaire | Q37148286 |
| | Cutaneous allodynia in the migraine population | Q37312063 |
| | Revised French guidelines for the diagnosis and management of migraine in adults and children | Q37529093 |
| | Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. | Q37861402 |
| | Advances and challenges in neurostimulation for headaches | Q38027732 |
| | Peripheral neurostimulation in primary headaches | Q38215469 |
| | Providing Care for Patients with Chronic Migraine: Diagnosis, Treatment, and Management | Q38255772 |
| | The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies | Q38323922 |
| | Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention | Q38348229 |
| | Quality of life in primary headache disorders: A review | Q38427435 |
| | Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study | Q39250004 |
| | Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation | Q39302875 |
| | EFNS guidelines on neurostimulation therapy for neuropathic pain | Q39331261 |
| | Migraine medication attributes important for patient compliance: concerns about side effects may delay treatment | Q39392586 |
| | Non-invasive vagus nerve stimulation for PREVention and Acute treatment of chronic cluster headache (PREVA): A randomised controlled study | Q40899001 |
| P433 | issue | 7 | |
| P304 | page(s) | 678-683 | |
| P577 | publication date | 2017-06-05 | |
| P1433 | published in | Neuromodulation | Q15758089 |
| P1476 | title | External Trigeminal Nerve Stimulation for the Acute Treatment of Migraine: Open-Label Trial on Safety and Efficacy | |
| P478 | volume | 20 | |